×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
New treatment landscape with immunotherapy for advanced oesophageal cancer patients: Register Now!

Register now to this webinar to participate and discuss in live with the experts!

0
Days
0
Hours
0
Minutes
0
Seconds


Monday, October 11th 2021
07:30pm to 09:30pm (GMT+2)

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
Add to calendar Notify me
 Browser notifications are enabled
19:30
Opening
Prof. Dr. Eric Van Cutsem, UZ Leuven
 
 
19:35
Current treatment landscape with anti-PD-1 therapy for advanced esophageal cancer
Prof. Dr. Marc Van den Eynde, Cliniques Universitaires Saint-Luc, Brussels
 
20:00 GI immune related adverse events management with anti-PD-1 therapy
Prof. Dr. Marc Peeters, UZ Antwerpen
 
20:15
Pause
 
20:30 CPS testing in esophageal cancer
Dr. Vasiliki Siozopoulou, UZ Antwerpen
 
20h40 Q&A session
Moderator: Prof. Dr. Eric Van Cutsem, UZ Leuven
 
21:10 Closing

In collaboration with

  
MSD Belgium SRL / BV
Clos du Lynx, 5, Lynx Binnernhof - Bruxelles 1200 Brussel

Abbreviations:

UZ: Universitair Ziekenhuis
PD-1: Programmed death ligand 1
CPS: Combined Positive Score
Q&A: Questions and answers
 
 
BE-KEY-00665
Date of last revision: 08/2021
Last update : 2021-08-17
Scroll Up